Keros Therapeutics Investors

35 investors on Angel Roster list Keros Therapeutics in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States, Israel and the United Kingdom.

Investors are matched on the company name in their portfolio, so companies that share the name Keros Therapeutics can appear together.

Investors listed
35
With verified email
54%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 35 Keros Therapeutics investors

The most complete profiles first. Showing 35 of 35.

  • Brett ZbarVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedInvestment Management

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 68 more

    Verified email available

  • Bryan RobertsVerified

    Venture Capital, Entrepreneurship Program, Private Equity Firm · United States

    Series BSeries AAdvertisingHealth CareTelecommunicationsWomen Founded

    Portfolio: Nightfall AI, Biolux Research, Cloudflare, Adavium and 82 more

    Verified email available

  • David BonitaVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 93 more

    Verified email available

  • Dennis RyanVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedLife Science

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more

    Verified email available

  • Dorothy MargolskeeVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedLife Science

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more

    Verified email available

  • Ethan BatraskiVerified

    Venture Capital, Entrepreneurship Program, Private Equity Firm · United States

    Series BSeries AAdvertisingHealth CareRemote Work TechTelecommunications

    Portfolio: Nightfall AI, Biolux Research, Dapper Labs, Constellation Pharmaceuticals and 66 more

    Verified email available

  • Geoffrey HsuVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Harry BarberVerified

    Venture Capital, Investor · United States

    Series BSeries AHealth CareTelecommunicationsWomen FoundedInvestment Management

    Portfolio: Nightfall AI, Biolux Research, Dapper Labs, Constellation Pharmaceuticals and 64 more

    Verified email available

  • Jim TananbaumVerified

    Venture Capital, Founder, Private Equity Firm · United States

    SeedHealth CareBiotechnologyConsumer HealthElectronic Health Records (EHR)

    Portfolio: Element Biosciences, Peloton Therapeutics, Genomics, Keros Therapeutics and 8 more

    Verified email available

  • Matt TaylorVerified

    Venture Capital, Advisor, Private Equity Firm · United Kingdom

    SeedHealth CareHospitalsWomen FoundedLife Science

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more

    Verified email available

  • Meredith FisherVerified

    Venture Capital, Investor · United States

    SeedHealth CareWellnessWomen FoundedLife Science

    Portfolio: CoStim Pharmaceuticals, Magenta Therapeutics, ImmuneXcite, InStore Finance and 23 more

    Verified email available

  • Nimish ShahVerified

    Venture Capital, Investor · United States

    Series AHealth CareTelecommunicationsWomen FoundedInvestment Management

    Portfolio: Nightfall AI, Biolux Research, Dapper Labs, Constellation Pharmaceuticals and 64 more

    Verified email available

  • Rhonda KaufmanVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedLife Science

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more

    Verified email available

  • Roger KittermanVerified

    Venture Capital, Investor · United States

    SeedHealth CareWellnessWomen FoundedLife Science

    Portfolio: CoStim Pharmaceuticals, Magenta Therapeutics, ImmuneXcite, InStore Finance and 23 more

    Verified email available

  • Todd GrahamVerified

    Venture Capital, Investor · United States

    Series AHealth CareTelecommunicationsCybersecurityWomen Founded

    Portfolio: Nightfall AI, Biolux Research, Dapper Labs, Constellation Pharmaceuticals and 64 more

    Verified email available

  • Alex RosenVerified

    Venture Capital · United States

    Health CareTelecommunicationsWomen FoundedInvestment Management

    Portfolio: Nightfall AI, Biolux Research, Dapper Labs, Constellation Pharmaceuticals and 64 more

    Verified email available

  • Jonathan SilversteinVerified

    Private Equity Firm · United States

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Jonathan WangVerified

    Private Equity Firm · China

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Rishi GuptaVerified

    Private Equity Firm · United States

    Health CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Andrew Gottesdiener

    Venture Capital, Investor · United States

    Series AHealth CareTelecommunicationsWomen FoundedInvestment Management

    Portfolio: Nightfall AI, Biolux Research, Dapper Labs, Constellation Pharmaceuticals and 64 more

    Contact details available

  • Carl Berke

    Venture Capital, Investor · United States

    SeedHealth CareWellnessWomen FoundedLife Science

    Portfolio: CoStim Pharmaceuticals, Magenta Therapeutics, ImmuneXcite, InStore Finance and 23 more

    Contact details available

  • Carter Neild

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Chau Khuong

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Gennao Bio, Yisheng Biopharma and 89 more

    Contact details available

  • Luke Bagaason, CFA

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedInvestment Management

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more

    Contact details available

  • Megan Blewett

    Venture Capital, Investor · United States

    SeedPre-SeedHealth CareTelecommunicationsWomen FoundedInvestment Management

    Portfolio: Nightfall AI, Biolux Research, Dapper Labs, Constellation Pharmaceuticals and 64 more

    Contact details available

  • Ran Nussbaum

    Venture Capital, Founder, Private Equity Firm · Israel

    Series BHealth CareLife ScienceInformation Technology (IT)Manufacturing

    Portfolio: Rewalk Robotics, VBI Vaccines, CathWorks, ProtAb and 48 more

    Contact details available

  • Richard Lau, CFA

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedInvestment Management

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more

    Contact details available

  • Scotland Stevens

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • ohad hammer

    Venture Capital, Scout, Private Equity Firm · Israel

    Series BHealth CareLife ScienceInformation Technology (IT)Manufacturing

    Portfolio: Rewalk Robotics, VBI Vaccines, CathWorks, ProtAb and 48 more

    Contact details available

  • Anat Naschitz

    Private Equity Firm · Israel

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Erez Chimovits

    Private Equity Firm · Israel

    Health CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Julius Knowles

    Venture Capital, Design Operator, Strategy Operator · United States

    Health CareHospitalsWellnessWomen Founded

    Portfolio: CoStim Pharmaceuticals, Magenta Therapeutics, ImmuneXcite, InStore Finance and 23 more

    Contact details available

  • Mike Tyrrell

    Venture Capital · United States

    Health CareTelecommunicationsWomen FoundedInvestment Management

    Portfolio: Nightfall AI, Biolux Research, Dapper Labs, Constellation Pharmaceuticals and 64 more

    Contact details available

  • Paul Dossa

    Venture Capital · United States

    Health CareTelecommunicationsWomen FoundedInvestment Management

    Portfolio: Nightfall AI, Biolux Research, Dapper Labs, Constellation Pharmaceuticals and 64 more

    Contact details available

  • Ruoxi Hu

    Venture Capital · United States

    Health CareWellnessWomen FoundedLife Science

    Portfolio: CoStim Pharmaceuticals, Magenta Therapeutics, ImmuneXcite, InStore Finance and 23 more

    Contact details available

Frequently asked questions

How many Keros Therapeutics investors are on Angel Roster?

Angel Roster lists 35 Keros Therapeutics investors. 19 of them (54%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (30), Private Equity Firms (22) and Investment Partner Investors (3). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Keros Therapeutics investors invest in?

Among those that list a stage, the most common are Seed (17), Series A (11) and Series B (5).

Where are Keros Therapeutics investors based?

Most are based in the United States (29), Israel (4) and the United Kingdom (1).

Which companies have Keros Therapeutics investors backed?

The most-backed portfolio companies among them are Olema Oncology (27), VelosBio (27), Element Biosciences (18), Delfi Diagnostics (17) and Crossover Health (17).

How do I contact Keros Therapeutics investors?

Create a free Angel Roster account to search and filter all 35, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.